|
Generic Name : Daunorubicin
Pronunciation : daw noe roo' bi sin
Therapeutic Classification : Chemotherapy
Trade Name(s):
India- Daunobin Vial , Daunocin Vial, Daunomycin Vial, Daunoplus Vial , Daunorubitec Vial , Daunoside Vial , Daunotec Vial , Norubin Vial. International- Cerubidine, DaunoXome. This medication is a chemotherapeutic agent, prescribed for acute myeloid leukemia and acute lymphocytic leukemia. This medication slows the growth and spread of cancer cells in the body. When it is not to be taken (Contraindications):
When it is to be taken : IV- Adult- The recommended dose is 60 – 75mg/m2/day BSA (body surface area), every 3 weeks. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein. Special Instruction : * Caution should be exercised in patients with heart, kidney or liver disease, bone marrow depression, gout, any allergy, who are taking other medications, children, during pregnancy and breastfeeding. * Patient may develop with increased risk of heart disease (myocardial toxicity), bone marrow depression and secondary malignancy (cancer); if it is so consult with your doctor immediately. * It may reduce platelet counts, which leads to bleeding; avoid injury or bruising. * Monitor complete blood cell counts, heart, liver and kidney functions regularly while taking this medication. * Avoid contact with people with infections. Side Effects : Skin - Rash, skin inflammation and hives. Gastrointestinal - Nausea, vomiting, diarrhea and abdominal pain. Local - Cell death and painful induration. Miscellaneous - Fever, chills and rarely allergic reactions. * Avoid drinking alcoholic beverages. * Avoid excess dosage. Storage Conditions : Injection: Store it in refrigerator (2-8°C). Do not freeze. Powder for injection: Store it at controlled room temperature (15-25°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||


